Pro Share Advisors LLC Castle Biosciences Inc Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$16.0 - $45.99 $106,000 - $304,683	-6,625 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$33.17 - $46.98 $52,839 - $74,839	-1,593 Reduced 19.38%	6,625 $298,000
Q4 2021 Feb 08, 2022	BUY	$39.06 - $67.58 $4,335 - $7,501	111 Added 1.37%	8,218 $352,000
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $115,690 - $149,302	-1,924 Reduced 19.18%	8,107 $539,000
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $138,093 - $211,759	2,758 Added 37.92%	10,031 $736,000

Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $92,681 - $153,100	1,573 Added 27.6%	7,273 $498,000
Q4 2020 Feb 09, 2021	BUY	$43.6 - $73.05 $47,567 - $79,697	1,091 Added 23.67%	5,700 $383,000
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $177,308 - $239,806	4,609 New	4,609 $237,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.